This pro-survival effect of HuR in pancreatic cancer cells was observed in several other studies, and additional HuR target genes like YAP1 and DR5/TNFRSF10B as well as their associated pathways have been shown to be activated or inhibited by HuR [138,139]. This evidence concerns the gene ELAVL1 and familial pancreatic carcinoma.